ITGB4 and triple-negative breast carcinoma: For example, ITGB4+ cancer stem cells have an intermediate epithelial/mesenchymal phenotype and elevated ITGB4 was associated with worse relapse-free survival in triple-negative breast cancer (TNBC) (51).